SEC Filings

Filing date Form Description View
CORRESP

CORRESP

View HTML
CORRESP

CORRESP

View HTML
CORRESP

CORRESP

View HTML
CORRESP

CORRESP

View HTML
CORRESP

CORRESP

View HTML
CORRESP

CORRESP

View HTML
DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

View HTML
DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

View HTML
EFFECT

EFFECT

View HTML
EFFECT

EFFECT

View HTML

Data provided by Kaleidoscope.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb